The clinical education
A normal result can be accurate and still be incomplete.
During perimenopause, ovarian function does not decline in a smooth, predictable line. Hormone levels can rise and fall, sometimes substantially. A blood draw captures one moment. It does not capture the entire transition.
For many women age 45 and older, clinicians can identify perimenopause from the pattern of symptoms, age, and menstrual-cycle changes without routine hormone testing. A follicle-stimulating hormone, or FSH, level that falls within a laboratory’s reference range does not automatically rule out perimenopause.
Laboratory testing should answer a clinical question. It should not be used to decide whether a woman’s experience is real.
When testing may add important information
Testing may be appropriate when the presentation is atypical, when another condition could be contributing, or when symptoms and cycle changes occur earlier than expected. Guidelines specifically support considering FSH testing in women ages 40 to 45 with menopause-associated symptoms and in women younger than 40 when premature ovarian insufficiency is suspected.
Depending on the individual history, evaluation may also include testing for pregnancy, thyroid disease, anemia, or other conditions that can overlap with menopause symptoms. The right question is not simply, “Are the hormones normal?” It is, “What information would change the assessment or the plan?”
Symptoms are clinical information. Menstrual history is clinical information. Age, medications, prior surgery, cancer treatment, family history, and health risks are clinical information. The laboratory value belongs inside that larger picture.

